Last reviewed 2026-04-20 · How we verify

Th2 Cells

At a glance

Approved indications

No approved indications tracked.

Common side effects

• ALT, SGPT (serum glutamic pyruvic transaminase)
• AST, SGOT(serum glutamic oxaloacetic transaminase)
• Acidosis (metabolic or respiratory)
• Adrenal insufficiency
• Albumin, serum-low (hypoalbuminemia)
• Alkaline phosphatase
• Alkalosis (metabolic or respiratory)
• Allergic reaction/hypersensitivity (including drug fever)
• Amylase
• Anorexia
• Bilirubin (hyperbilirubinemia)
• Calcium, serum-high (hypercalcemia)

Key clinical trials

• Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP (NA)
• RAPA-501 Therapy of ALS Expanded Access Protocol
• Distribution of Immune Cells Subsets in Healthy Females (NA)
• Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy
• SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
• Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis (NA)
• RAPA-501 Therapy for ALS (PHASE2, PHASE3)
• Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2) (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.